2,991
Views
29
CrossRef citations to date
0
Altmetric
Research Papers

Parents’ decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results

, , , , &
Pages 330-336 | Received 01 Aug 2014, Accepted 17 Sep 2014, Published online: 31 Mar 2015

References

  • Shearer BD. HPV vaccination: Understanding the impact of HPV disease. Purple Paper: Natl Collaborating Centre Infect Dis 2011 [Internet]; 34: 1-18. Available from: www.nccid.ca/files/Purple_Paper_Note_mauve/PP_34_EN.pdf
  • Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325:572-6; PMID:12228133; http://dx.doi.org/10.1136/bmj.325.7364.572
  • Myers ER. The economic impact of HPV vaccines: not just cervical cancer. Am J Obstet Gynecol 2008; 198:487-8; PMID:18455522; http://dx.doi.org/10.1016/j.ajog.2008.03.056
  • de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607-15; PMID:22575588; http://dx.doi.org/10.1016/S1470-2045(12)70137-7
  • Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24:S1-S10; PMID:16949995
  • Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013; 13:39; PMID:23347441; http://dx.doi.org/10.1186/1471-2334-13-39
  • Cubie HA. Diseases associated with human papillomavirus infection. Virology 2013; 445:21-34; PMID:23932731; http://dx.doi.org/10.1016/j.virol.2013.06.007
  • Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30 Suppl 5:F123-38; PMID:23199956; http://dx.doi.org/10.1016/j.vaccine.2012.04.108
  • Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet 2013; 382:889-99.
  • National Advisory Committee on Immunization. Statement on human papillomavirus vaccine. Can Commun Dis Rep 2007 [Internet]; 33:1-32. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-02/index-eng.php
  • Canadian Immunization Committee. Recommendations for human papillomavirus immunization programs. Can. Commun. Dis. Rep. 2014 [Internet]; 40: 1-48. Available from: http://publications.gc.ca/site/eng/464264/publication.html
  • Eggertson L. Provinces weighing HPV vaccination of boys. Can Med Assoc J 2012; 184:E250-1; PMID:22371513; http://dx.doi.org/10.1503/cmaj.109-4140
  • National Advisory Committee on Immunization. Update on human papillomavirus (HPV) vaccines [Internet]. Can Commun Dis Rep, 2012; 38:1-62 [Internet]. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-1/index-eng.php
  • The Society of Obstetricians and Gynaecologists of Canada. Alberta and PEI will include boys in HPV vaccination programs. Ottawa (Ontario): The Society of Obstetricians and Gynaecologists of Canada; 2013 [cited 2014 August 1]. Available from: http://sogc.org/news_items/alberta-and-pei-will-include-boys-in-hpv-vaccination-programs/
  • Comité, Québec slid. HPV Immunization of Québec Pre-Adolescents: Two or Three Doses? In: Sauvageau C, Gilca V, eds. Quebec: Institut national de santé publique du Québec, 2013.
  • Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004; 8:188-94; PMID:15874862; http://dx.doi.org/10.1097/00128360-200407000-00005
  • Walhart T. Parents, adolescents, children and the human papillomavirus vaccine: a review. Int Nurs Rev 2012; 59:305-11; PMID:22897180; http://dx.doi.org/10.1111/j.1466-7657.2012.00991.x
  • Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med 2013; 57:414-8; PMID:23732252; http://dx.doi.org/10.1016/j.ypmed.2013.05.013
  • Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transmitted Dis 2003; 30:774-8; PMID:14520177; http://dx.doi.org/10.1097/01.OLQ.0000078823.05041.9E
  • Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013
  • Liau A, Stupiansky NW, Rosenthal SL, Zimet GD. Health beliefs and vaccine costs regarding human papillomavirus (HPV) vaccination among a U.S. national sample of adult women. Prev Med 2012; 54:277-9; PMID:22342703; http://dx.doi.org/10.1016/j.ypmed.2012.02.002
  • Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007; 40:108-15; PMID:17259050; http://dx.doi.org/10.1016/j.jadohealth.2006.10.007
  • Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012; 30:4939-44; PMID:22664223; http://dx.doi.org/10.1016/j.vaccine.2012.05.053
  • Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV. Health Educ Behav 2007; 34:471-85; PMID:17000622; http://dx.doi.org/10.1177/1090198106292022
  • Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K. Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women. J Adolesc Health 2012; 50:464-70; PMID:22525109; http://dx.doi.org/10.1016/j.jadohealth.2011.09.005
  • Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012; 166:82-8; PMID:22213755; http://dx.doi.org/10.1001/archpediatrics.2011.186
  • Kwan TT, Tam KF, Lee PW, Lo SS, Chan KK, Ngan HY. De-stigmatising human papillomavirus in the context of cervical cancer: a randomised controlled trial. Psychooncology 2010; 19:1329-39; PMID:20186874; http://dx.doi.org/10.1002/pon.1706
  • Forster A, Wardle J, Stephenson J, Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun 2010; 15:205-17; PMID:20390987; http://dx.doi.org/10.1080/10810730903528066
  • Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: A systematic review from 2001 to 2011. Obstet Gynecol Int 2012; 2012:921236; PMID:21977039; http://dx.doi.org/10.1155/2012/921236
  • Comoro C, Nsimba SED, Warsame M, Tomson G. Local understanding, perceptions and reported practices of mothers/guardians and health workers on childhood malaria in a Tanzanian district—implications for malaria control. Acta Trop 2003; 87:305-13; PMID:12875923; http://dx.doi.org/10.1016/S0001-706X(03)00113-X
  • Ray-Mazumder S. Role of gender, insurance status and culture in attitudes and health behavior in a US Chinese student population. Ethn Health 2001; 6:197-209; PMID:11696931; http://dx.doi.org/10.1080/13557850120078125
  • Bouliane N BR, Audet D, Ouaki M. Enquête Sur la Couverture Vaccinale Des Enfants de 1 an et 2 Ans au Québec en 2012. Québec (Qc): Institut National de Sante Publique du Québec; 2013 January, 223p. Available from: http://www.inspq.qc.ca/pdf/publications/1651_EnquCouvVaccinEnfants1Et2Ans2012.pdf
  • Krawczyk A, Knäuper B, Gilca V, Dubé E, Joyal-Desmarais K, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Hum Vaccin Immunother 2015; 11:21-8.
  • Romanowski B, Schwarz TF, Ferguson LM, Peters K, Dionne M, Schulze K, Ramjattan B, Hillemanns P, Catteau G, Dobbelaere K, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Hum Vaccin 2011; 7:1374-86; PMID:22048171; http://dx.doi.org/10.4161/hv.7.12.18322
  • Romanowski B, Schwarz TF, Ferguson LM, Ferguson M, Peters K, Dionne M, Schulze K, Ramjattan B, Hillemanns P, Behre U, et al. Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study. Hum Vaccin Immunother 2014; 10:1155-65; PMID:24576907; http://dx.doi.org/10.4161/hv.28022
  • Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: Wiley & Sons, 1978.
  • Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer BK, Viswanath K, eds. Health Behavior and Health Education: Theory, Research, and Practice. San Francisco, CA: Jossey-Bass, 2008:45-65.
  • Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010; 28:4027-37; PMID:20412875; http://dx.doi.org/10.1016/j.vaccine.2010.03.063
  • Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knauper B, Rosberger Z. Human papillomavirus vaccination intentions and uptake in college women. Health Psyc 2012; 31:685-93; PMID:22268713; http://dx.doi.org/10.1037/a0027012
  • Perkins RB, Tipton H, Shu E, Marquez C, Belizaire M, Porter C, Clark JA, Pierre-Joseph N. Attitudes toward HPV vaccination among low-income and minority parents of sons: a qualitative analysis. Clin Pediatr (Phila) 2013; 52:231-40; PMID:23362316; http://dx.doi.org/10.1177/0009922812473775
  • Glanz K, Rimer BK, Viswanath K. Health Behavior and Health Education: Theory, Research, and Practice. San Francisco, CA: Jossey-Bass, 2008.
  • Patton MQPMQ. Qualitative Research & Evaluation Methods. Thousand Oaks, Calif; London: Sage, 2002.
  • Smith CP. Content analysis and narrative analysis. In: Reis HTJCM, ed. Handbook of Research Methods in Social and Personality Psychology. New York: Cambridge University Press, 2000, 313-35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.